Literature DB >> 2260851

Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment.

L Berg1, D S Smith, J C Morris, J P Miller, E H Rubin, M Storandt, L A Coben.   

Abstract

Sixty-six subjects diagnosed by validated criteria as having senile dementia of the Alzheimer type (SDAT) were assessed with clinical measures commonly used to study dementia. The severity of the SDAT was mild in 24, moderate in 24, and severe in 18. The data from these three groups in a cross-sectional study were compared with results in our earlier study of 43 subjects enrolled with mild SDAT and followed longitudinally. We concluded that the cross-sectional method underestimates the severity of progression as indicated by some of the clinical measures. Additionally, the 24 new subjects with mild SDAT were assessed longitudinally. This replication study confirmed our earlier conclusions that four of six clinical measures showed similar patterns over time and were useful throughout the study, global measures being more informative than brief individual measures with ceiling or floor effects.

Entities:  

Mesh:

Year:  1990        PMID: 2260851     DOI: 10.1002/ana.410280508

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.

Authors:  Susan D Rountree; Wenyaw Chan; Valory N Pavlik; Eveleen J Darby; Samina Siddiqui; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2009-10-21       Impact factor: 6.982

2.  Informant-based dementia screening in a population-based sample of African Americans.

Authors:  Theodore K Malmstrom; Douglas K Miller; Mary A Coats; Pamela Jackson; J Philip Miller; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

Review 3.  Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.

Authors:  J Jolles; F R Verhey; W J Riedel; P J Houx
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.